---
figid: PMC10523235__WJD-14-1369-g006
pmcid: PMC10523235
image_filename: WJD-14-1369-g006.jpg
figure_link: /pmc/articles/PMC10523235/figure/F6/
number: Figure 6
figure_title: ''
caption: 'Knockdown of XB130 attenuated hyperglycemia-induced inhibitory effects on
  proliferation and tubule formation of human umbilical vein endothelial cells. A:
  Western blot analysis of XB130 protein expression in human umbilical vein endothelial
  cells; B: Quantification of Western blot results; C: Immunofluorescence staining
  of Bax, cleaved caspase-3, PCNA, Ki67, and Bcl2 in each group; D: Wound healing
  assay in each group, scale bars = 200 μm; E: Capillary-like tubule formation, scale
  bars = 200 μm. aP < 0.001, compared to the high glucose group; bP < 0.001, compared
  to the HG + Vector group.'
article_title: XB130 inhibits healing of diabetic skin ulcers through the PI3K/Akt
  signalling pathway.
citation: Xin-Lin Zhu, et al. World J Diabetes. 2023 Sep 15;14(9):1369-1384.
year: '2023'

doi: 10.4239/wjd.v14.i9.1369
journal_title: World Journal of Diabetes
journal_nlm_ta: World J Diabetes
publisher_name: Baishideng Publishing Group Inc

keywords:
- XB130
- Diabetes mellitus
- Diabetic skin ulcers
- PI3K/Akt signalling pathway

---
